Zenas BioPharma, Inc. ZBIO
27.75 USD -0.18 (-0.64%)
Regular-session close
29.33 +1.58 +5.69%
After hours · Nov 17, 4:33 PM ET
27.00 Day range 28.13
13.50 52-week range 44.60
- YTD
- -23.57%
- 1 year
- -22.66%
News
globenewswire.com Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease - New patient and physician surveys reveal differing perspectives on disease burden, treatment goals, and long-term management - WALTHAM, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma,…
defenseworld.net Zenas BioPharma, Inc. $ZBIO Shares Acquired by Alps Advisors Inc. Alps Advisors Inc. increased its position in shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) by 35.6% during the undefined quarter, according to its most recent disclosure with the Securities and…benzinga.com Zenas BioPharma Q3 EPS $(1.65) Misses $(1.33) Estimate, Sales $10.000M Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(1.33) by 24.06 percent. This is a 35.25 percent decrease over losses of…
